Treatment outcomes following continuous miglustat therapy in
Por um escritor misterioso
Last updated 21 outubro 2024
Background Niemann-Pick disease Type C (NP-C) is a rare, progressive neurodegenerative disorder characterized by progressive neurodegeneration and premature death. We report data at closure of the NPC Registry that describes the natural history, disease course and treatment experience of NP-C patients in a real-world setting. Methods The NPC Registry was a prospective observational cohort study that ran between September 2009 and October 2017. Patients with a confirmed diagnosis of NP-C were enrolled regardless of treatment status. All patients underwent clinical assessments and medical care as determined by their physicians; data were collected through a secure internet-based portal. Results At closure on October 19, 2017, 472 patients from 22 countries were enrolled in the NPC Registry. Mean (standard deviation) age at enrollment was 21.2 (15.0) years, and 51.9% of patients were male. First neurological symptom onset occurred during the early-infantile (< 2 years), late-infantile (2 to < 6 years), juvenile (6 to < 15 years), or adolescent/adult (≥ 15 years) periods in 13.5, 25.6, 31.8, and 29.1% of cases, respectively. The most frequent neurological manifestations prior to enrollment included ataxia (67.9%), vertical supranuclear gaze palsy (67.4%), dysarthria (64.7%), cognitive impairment (62.7%), dysphagia (49.1%), and dystonia (40.2%). During infancy, splenomegaly and hepatomegaly were frequent (n = 199/398 [50%] and n = 147/397 [37.0%], respectively) and persisted in most affected patients. Of the 472 enrolled patients, 241 were continuously treated with miglustat during the NPC Registry observation period, of whom 172 of these 241 patients were treated continuously for ≥12 months. A composite disability score that assesses impairment of ambulation, manipulation, language, and swallowing was highest in the early-infantile population and lowest in the adolescent/adult population. Among the continuous miglustat therapy population, 70.5% of patients had improved or had stable disease (at least 3 of the 4 domains having a decreased or unchanged score between enrollment and last follow-up). The NPC Registry did not identify any new safety signals associated with miglustat therapy. Conclusions The profiles of clinical manifestations in the final NPC Registry dataset agreed with previous clinical descriptions. Miglustat therapy was associated with a stabilization of neurological manifestations in most patients. The safety and tolerability of miglustat therapy was consistent with previous reports.
JCM, Free Full-Text
These highlights do not include all the information needed to use
Recommendations for oral treatment for adult patients with type 1
Tolerance of chronic HDACi treatment for neurological, visceral
Full article: New therapies in the management of Niemann-Pick type
PDF) Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ
Effects of miglustat therapy on neurological disorder and survival
PDF] Miglustat for treatment of Niemann-Pick C disease: a
Frontiers Therapeutic Strategies For Tay-Sachs Disease
Therapies and Upcoming Treatments
Long‐term efficacy of miglustat in paediatric patients with
CNS-accessible Inhibitor of Glucosylceramide Synthase for
Proportions of patients who received continuous miglustat therapy
Orphazyme's arimoclomol to be used with Zavesca after FDA approval
Recomendado para você
-
Niemann-Pick Type C « Niemann-Pick Children's Fund, Inc21 outubro 2024
-
A new regulatory mechanism of STARD1 in Niemann-Pick disease type C (NPC), discovered21 outubro 2024
-
Niemann-Pick disease type C21 outubro 2024
-
Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases21 outubro 2024
-
Niemann–Pick Disease Type C21 outubro 2024
-
National Niemann-Pick Disease Foundation, Inc. - October is21 outubro 2024
-
Niemann Pick Disease - Rivin21 outubro 2024
-
Niemann–Pick disease21 outubro 2024
-
Diagnostic and predictive methods for a Niemann-Pick disease type21 outubro 2024
-
Rare Diseases India on X: Niemann-Pick is a rare, inherited21 outubro 2024
você pode gostar
-
Kids Preschool Learning Games PC - Free Game Download21 outubro 2024
-
Sea of Thieves - Support - Twitch Drops21 outubro 2024
-
Smithsonian Dinosaur Atlas – Treehouse Toys21 outubro 2024
-
Jogo De Olho na Escola - De Olho nos Planos21 outubro 2024
-
Evil Dead Movies In Order, Including 'Evil Dead Rise' - Parade21 outubro 2024
-
sean auf X: „Face reveal. Life of a discord admin / X21 outubro 2024
-
Monkey D. Luffy do One Piece. Imagens do anime e dos jogos.21 outubro 2024
-
Steam Community :: :: ScPeanut-17321 outubro 2024
-
craven philosophical designing21 outubro 2024
-
Roblox Free Gift cards21 outubro 2024